[av_section min_height=» min_height_px=’500px’ padding=’default’ shadow=’no-shadow’ bottom_border=’no-border-styling’ bottom_border_diagonal_color=’#333333′ bottom_border_diagonal_direction=» bottom_border_style=» id=» color=’main_color’ custom_bg=’#ffffff’ src=» attachment=» attachment_size=» attach=’scroll’ position=’top left’ repeat=’no-repeat’ video=» video_ratio=’16:9′ overlay_opacity=’0.5′ overlay_color=» overlay_pattern=» overlay_custom_pattern=» av_element_hidden_in_editor=’0′]
[av_one_fourth first min_height=» vertical_alignment=» space=» custom_margin=» margin=’0px’ padding=’0px’ border=» border_color=» radius=’0px’ background_color=» src=» background_position=’top left’ background_repeat=’no-repeat’ animation=» mobile_display=»]

[av_font_icon icon=’ue80b’ font=’entypo-fontello’ style=’border’ caption=» link=» linktarget=» size=’130px’ position=’center’ color=’#22689e’ admin_preview_bg=»][/av_font_icon]

[/av_one_fourth][av_three_fourth min_height=» vertical_alignment=» space=» custom_margin=» margin=’0px’ padding=’0px’ border=» border_color=» radius=’0px’ background_color=» src=» background_position=’top left’ background_repeat=’no-repeat’ animation=» mobile_display=»]

[av_heading heading=’Grupo de Trabajo de Opioides’ tag=’h2′ style=’blockquote modern-quote’ size=’20’ subheading_active=» subheading_size=’15’ padding=’10’ color=’custom-color-heading’ custom_font=’#22689e’ admin_preview_bg=»][/av_heading]

[av_hr class=’custom’ height=’50’ shadow=’no-shadow’ position=’left’ custom_border=’av-border-thin’ custom_width=’100%’ custom_border_color=’#22689e’ custom_margin_top=’0px’ custom_margin_bottom=’10px’ icon_select=’no’ custom_icon_color=’#22689e’ icon=’ue8bf’ font=’entypo-fontello’ admin_preview_bg=»]

[av_textblock size=» font_color=» color=» admin_preview_bg=»]
Coordinador:
Fernando Neira Reina.

Vocales: 
J. Luisa Ortega García (portavoz de la JD), Sebastián Perales Recio. Ignacio Velázquez Rivera.
[/av_textblock]

[/av_three_fourth]
[/av_section]

[av_section min_height='' min_height_px='100px' padding='no-padding' shadow='no-border-styling' bottom_border='no-border-styling' bottom_border_diagonal_color='#333333' bottom_border_diagonal_direction='' bottom_border_style='' scroll_down='aviaTBscroll_down' id='' color='main_color' custom_bg='#22689e' src='' attachment='' attachment_size='' attach='scroll' position='top left' repeat='no-repeat' video='' video_ratio='16:9' overlay_opacity='0.5' overlay_color='' overlay_pattern='' overlay_custom_pattern='' av_element_hidden_in_editor='0']
[av_hr class='invisible' height='10' shadow='no-shadow' position='left' custom_border='av-border-thin' custom_width='100%' custom_border_color='#22689e' custom_margin_top='0px' custom_margin_bottom='10px' icon_select='no' custom_icon_color='#22689e' icon='ue8bf' font='entypo-fontello' admin_preview_bg='']
[/av_section]

[av_section min_height='' min_height_px='500px' padding='default' shadow='no-shadow' bottom_border='no-border-styling' bottom_border_diagonal_color='#333333' bottom_border_diagonal_direction='scroll' bottom_border_style='scroll' scroll_down='' id='' color='main_color' custom_bg='' src='' attach='scroll' position='top left' repeat='no-repeat' video='' video_ratio='16:9' video_mobile_disabled='' overlay_enable='' overlay_opacity='0.5' overlay_color='' overlay_pattern='' overlay_custom_pattern='' av_element_hidden_in_editor='0']
[av_one_full first min_height='' vertical_alignment='' space='' custom_margin='' margin='0px' padding='0px' border='' border_color='' radius='0px' background_color='' src='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_heading tag='h2' padding='10' heading='Documentación específica para Socios de la AAD' color='custom-color-heading' style='blockquote modern-quote' custom_font='#22689e' size='20' subheading_active='' subheading_size='15' custom_class='' admin_preview_bg=''][/av_heading]

[av_hr class='custom' height='50' shadow='no-shadow' position='left' custom_border='av-border-thin' custom_width='100%' custom_border_color='#22689e' custom_margin_top='0px' custom_margin_bottom='10px' icon_select='no' custom_icon_color='#22689e' icon='ue8bf' font='entypo-fontello' admin_preview_bg='']

[av_textblock size='' font_color='' color='' admin_preview_bg='']
[usersultra_protect_content display_rule='logged_in_based' custom_message_loggedin='Debe acceder como socio para visualizar estos contenidos']

[av_button_big label='Pulse aquí para acceder' description_pos='below' link='manually,/grupos-de-trabajo/grupo-de-trabajo-de-opioides/opioides-documentacion-para-socios-aad/' link_target='' icon_select='yes-left-icon' icon='ue825' font='entypo-fontello' custom_font='#ffffff' color='theme-color' custom_bg='#444444' color_hover='theme-color-subtle' custom_bg_hover='#000000' admin_preview_bg='']
Documentos específicos para Socios de la AAD
[/av_button_big]

[/usersultra_protect_content]
[/av_textblock]

[/av_one_full]
[/av_section]

[av_section min_height='' min_height_px='100px' padding='no-padding' shadow='no-border-styling' bottom_border='no-border-styling' bottom_border_diagonal_color='#333333' bottom_border_diagonal_direction='' bottom_border_style='' scroll_down='aviaTBscroll_down' id='' color='main_color' custom_bg='#22689e' src='' attachment='' attachment_size='' attach='scroll' position='top left' repeat='no-repeat' video='' video_ratio='16:9' overlay_opacity='0.5' overlay_color='' overlay_pattern='' overlay_custom_pattern='' av_element_hidden_in_editor='0']
[av_hr class='invisible' height='-50' shadow='no-shadow' position='left' custom_border='av-border-thin' custom_width='100%' custom_border_color='#22689e' custom_margin_top='0px' custom_margin_bottom='10px' icon_select='no' custom_icon_color='#22689e' icon='ue8bf' font='entypo-fontello' admin_preview_bg='']
[/av_section]

[av_section min_height='' min_height_px='500px' padding='default' shadow='no-shadow' bottom_border='no-border-styling' bottom_border_diagonal_color='#333333' bottom_border_diagonal_direction='scroll' bottom_border_style='scroll' scroll_down='' id='' color='main_color' custom_bg='' src='' attach='scroll' position='top left' repeat='no-repeat' video='' video_ratio='16:9' video_mobile_disabled='' overlay_enable='' overlay_opacity='0.5' overlay_color='' overlay_pattern='' overlay_custom_pattern='' av_element_hidden_in_editor='0']

[av_one_full first min_height='' vertical_alignment='' space='' custom_margin='' margin='0px' padding='0px' border='' border_color='' radius='0px' background_color='' src='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_heading tag='h2' padding='10' heading='Artículos y Descargas' color='custom-color-heading' style='blockquote modern-quote' custom_font='#22689e' size='20' subheading_active='' subheading_size='15' custom_class='' admin_preview_bg=''][/av_heading]

[av_hr class='custom' height='50' shadow='no-shadow' position='left' custom_border='av-border-thin' custom_width='100%' custom_border_color='#22689e' custom_margin_top='0px' custom_margin_bottom='10px' icon_select='no' custom_icon_color='#22689e' icon='ue8bf' font='entypo-fontello' admin_preview_bg='']

[/av_one_full][av_one_third first min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='ue84e' font='entypo-fontello' title='Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication' link='manually,https://onlinelibrary.wiley.com/doi/10.1002/pds.5118' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg='']
Diana González‐Bermejo Pilar Rayón‐Iglesias Alfonso Rodríguez‐Pascual Arturo Álvarez‐Gutiérrez Ana Fernández‐Dueñas Dolores Montero‐Corominas Consuelo Huerta‐Álvarez
[/av_icon_box]

[/av_one_third][av_one_third min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='uf0ed' font='font-awesome' title='Eficacia y tolerabilidad a largo plazo del tratamiento del dolor con Tapentadol de liberación prolongada' link='manually,http://new.asociacionandaluzadeldolor.es/wp-content/uploads/2021/03/tapentadol-2020.pdf' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg='']
The central analgesic tapentadol prolonged release (PR) has proven effective and generally well tolerated in a broad range of chronic pain conditions. Long-term data of its use are still scarce.
[/av_icon_box]

[/av_one_third][av_one_third min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='ue84e' font='entypo-fontello' title='Tapentadol de liberación prolongada para el tratamiento a largo plazo del dolor en niños' link='manually,https://www.dovepress.com/tapentadol-prolonged-release-for-long-term-treatment-of-pain-in-childr-peer-reviewed-fulltext-article-JPR' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg='']
El tapentadol PR fue bien tolerado y equivalente a la morfina PR para la eficacia y seguridad en niños (6 a 18 años de edad) que requiere tratamiento a largo plazo con opioides.
[/av_icon_box]

[/av_one_third][av_one_third first min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='ue84e' font='entypo-fontello' title='CDC guideline for prescribing opioids for chronic pain — United States, 2016' link='manually,https://www.guidelines.gov/summaries/summary/50153/cdc-guideline-for-prescribing-opioids-for-chronic-pain—united-states-2016?q=opioids' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg=''][/av_icon_box]

[/av_one_third][av_one_third min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='ue84e' font='entypo-fontello' title='Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration: an updated report by the American Society of Anesthesiologists Task Force on Neuraxial Opioids and the American Society of Regional Anesthesia and Pain Medicine' link='manually,https://www.guidelines.gov/summaries/summary/50071/practice-guidelines-for-the-prevention-detection-and-management-of-respiratory-depression-associated-with-neuraxial-opioid-administration-an-updated-report-by-the-american-society-of-anesthesiologists-task-force-on-neuraxial-opioids-and-the-american-society-of?q=opioids' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg=''][/av_icon_box]

[/av_one_third][av_one_third min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='uf0ed' font='font-awesome' title='A Guideline for the Clinical Management of Opioid Use Disorder' link='manually,http://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/bc_oud_guidelines.pdf' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg=''][/av_icon_box]

[/av_one_third][av_one_third first min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='uf0ed' font='font-awesome' title='European Pain Federation position paper on appropriate opioid use in chronic pain management' link='manually,/wp-content/uploads/2017/02/European-Pain-Federation-2016213-19.pdf' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg=''][/av_icon_box]

[/av_one_third][av_one_third min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='uf0ed' font='font-awesome' title='Evaluación de la calidad de atención al paciente anciano con dolor crónico y dolor irruptor en tratamiento con opioides. Estudio SAND' link='manually,/wp-content/uploads/2017/02/poster-estudio-sand.pdf' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg=''][/av_icon_box]

[/av_one_third][av_one_third min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='ue84e' font='entypo-fontello' title='Guideline for opioid therapy and chronic noncancer pain. CMAJ May 8, 2017 vol. 189 no. 18 doi: 10.1503/cmaj.170363' link='manually,http://www.cmaj.ca/content/189/18/E659' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg=''][/av_icon_box]

[/av_one_third][av_one_third first min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='ue84e' font='entypo-fontello' title='British Columbia Centre on Substance Use and B.C. Ministry of Health. A Guideline for the Clinical Management of Opioid Use Disorder. Published June 5, 2017' link='manually,http://www.bccsu.ca/care-guidance-publications/' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg=''][/av_icon_box]

[/av_one_third][av_one_third min_height='' vertical_alignment='av-align-top' space='' custom_margin='aviaTBcustom_margin' margin='0px' margin_sync='true' padding='0px' padding_sync='true' border='' border_color='' radius='0px' radius_sync='true' background_color='' src='' attachment='' attachment_size='' background_position='top left' background_repeat='no-repeat' animation='' mobile_display='']

[av_icon_box position='top' icon_style='' boxed='' icon='ue84e' font='entypo-fontello' title='Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, Constine LS, Cooper A, Glare P, Keefe F, Koyyalagunta L, Levy M, Miaskowski C, Otis-Green S, Sloan P, Bruera E. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016 Sep 20;34(27):3325-45.' link='manually,https://www.guideline.gov/summaries/summary/50478/management-of-chronic-pain-in-survivors-of-adult-cancers-american-society-of-clinical-oncology-clinical-practice-guideline' linktarget='_blank' linkelement='both' font_color='' custom_title='' custom_content='' color='custom' custom_bg='#22689e' custom_font='#ffffff' custom_border='#22689e' admin_preview_bg='']
[114 references]
[/av_icon_box]

[/av_one_third][/av_section]